Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Calgary

$25,000.00

Novel microfluidic electrochemical biosensor for rapid diagnosis of biomarkers

FY 2017-18

Summary
Immunosensors are very known among different types of biosensors for rapid diagnosis of biomarkers in bodilyfluids. The label-format of immunosensors allows for flexible implementation of biosensing in a wide range ofdetection schemes. However, these systems are limited in very high sensitive detection of minutes of moleculesin complex biological samples. There is also a trade-off in the time, cost and additional steps associated withincorporating reporter molecules into the label-based process. Moreover, the use of optical detection systems inpoint-of-care devices has one more constraint in detection of multiple biomarkers simultaneously in a singlemultiplexed biosensor as they require an external light source, optical transducer and other optical componentslike lenses and reflectors, which makes the detection system bulky and complex. Among various types oflabel-free detection techniques, the electrochemical sensing is the simplest to integrate, highly sensitive andmore compatible with multiplexing and integration into microfluidics, which makes it ideal for point-of-carediagnosis.In this work, we will develop an integrated and autonomous microfluidic-based biosensor for rapid detection ofbrain injury biomarkers. A new bonding technology will be developed to adhere electrodes to microfluidiclayers noninvasively to enable efficient performance of electrodes and point-of-care detection of biomarkers. Ifsuccessful, the microfluidic nano-biosensor proposed in this work will be used for rapid diagnosis of threedifferent biomarkers of brain injury in blood samples of patients in less than an hour. The expertise of theapplicant in microfluidics and biosensors ensures the success of this project.Sensoreal Inc. will benefit from label-free biosensors to extend the application of their technology for rapid andautomated detection of multiple biomarkers in human biological samples using a point-of-care diagnostictechnology. The lower cost and predictive point of care sensors will enable the rapid and large scale diseasescreening and facilitate monitoring the efficacy of therapeutics, therefore benefit the health system in Canada.
Program
Engage Grants Program
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
515726-2017
Name nom
SanatiNezhad, Amir
Department département
Mechanical and Manufacturing Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2100
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical engineering
Research subject fr
Génie mécanique
Partie
1
Nb partie
1
Application title
Novel microfluidic electrochemical biosensor for rapid diagnosis of biomarkers
Keyword
NSERC
Application summary
Immunosensors are very known among different types of biosensors for rapid diagnosis of biomarkers in bodilyfluids. The label-format of immunosensors allows for flexible implementation of biosensing in a wide range ofdetection schemes. However, these systems are limited in very high sensitive detection of minutes of moleculesin complex biological samples. There is also a trade-off in the time, cost and additional steps associated withincorporating reporter molecules into the label-based process. Moreover, the use of optical detection systems inpoint-of-care devices has one more constraint in detection of multiple biomarkers simultaneously in a singlemultiplexed biosensor as they require an external light source, optical transducer and other optical componentslike lenses and reflectors, which makes the detection system bulky and complex. Among various types oflabel-free detection techniques, the electrochemical sensing is the simplest to integrate, highly sensitive andmore compatible with multiplexing and integration into microfluidics, which makes it ideal for point-of-carediagnosis.In this work, we will develop an integrated and autonomous microfluidic-based biosensor for rapid detection ofbrain injury biomarkers. A new bonding technology will be developed to adhere electrodes to microfluidiclayers noninvasively to enable efficient performance of electrodes and point-of-care detection of biomarkers. Ifsuccessful, the microfluidic nano-biosensor proposed in this work will be used for rapid diagnosis of threedifferent biomarkers of brain injury in blood samples of patients in less than an hour. The expertise of theapplicant in microfluidics and biosensors ensures the success of this project.Sensoreal Inc. will benefit from label-free biosensors to extend the application of their technology for rapid andautomated detection of multiple biomarkers in human biological samples using a point-of-care diagnostictechnology. The lower cost and predictive point of care sensors will enable the rapid and large scale diseasescreening and facilitate monitoring the efficacy of therapeutics, therefore benefit the health system in Canada.